Although bone marrow stromal cells (BMSCs) appear promising for cartilage repair, current clinical results are suboptimal and the success of BMSC-based therapies relies on a number of methodological improvements, among which is better understanding and control of their differentiation pathways. We investigated here the role of the cellular environment (paracrine vs juxtacrine signalling) in the chondrogenic differentiation of BMSCs. Bovine BMSCs were encapsulated in alginate beads, as dispersed cells or as small micro-aggregates, to create different paracrine and juxtacrine signalling conditions. BMSCs were then cultured for 21 days with TGFß3 added for 0, 7 or 21 days. Chondrogenic differentiation was assessed at the gene (type II and X co...
Background Although mesenchymal stem/stromal cell (MSC) chondrogenic differentiation has been thoro...
Chondrocyte-based tissue engineering therapies require in vitro cell expansion, which is associated ...
Mesenchymal stem cells (MSCs) have been considered as a promising cell source for cartilage tissue r...
Although bone marrow stromal cells (BMSCs) appear promising for cartilage repair, current clinical r...
International audienceAlthough bone marrow stromal cells (BMSCs) appear promising for cartilage repa...
Cell therapies for articular cartilage defects rely on expanded chondrocytes. Mesenchymal stem cells...
Due to the limited intrinsic healing ability of mature cartilage tissue, stem cell therapies offer t...
Cartilage damaging injuries or degenerative diseases like osteoarthritis are restrictive and painful...
Bone marrow-derived stromal cells (BMSCs) are good candidates for cell-based tissue regeneration. Fo...
Chondrogenesis of mesenchymal stem cells (MSCs) is typically induced when they are condensed into a ...
Cell therapy combined with biomaterial scaffolds is used to treat cartilage defects. We hypothesized...
Mesenchymal stem cells (MSCs) have been previously explored as a part of cell-based therapies for th...
Virtually all bone marrow-derived stromal cell (BMSC) chondrogenic induction cultures include greate...
Background Although mesenchymal stem/stromal cell (MSC) chondrogenic differentiation has been thoro...
Chondrocyte-based tissue engineering therapies require in vitro cell expansion, which is associated ...
Mesenchymal stem cells (MSCs) have been considered as a promising cell source for cartilage tissue r...
Although bone marrow stromal cells (BMSCs) appear promising for cartilage repair, current clinical r...
International audienceAlthough bone marrow stromal cells (BMSCs) appear promising for cartilage repa...
Cell therapies for articular cartilage defects rely on expanded chondrocytes. Mesenchymal stem cells...
Due to the limited intrinsic healing ability of mature cartilage tissue, stem cell therapies offer t...
Cartilage damaging injuries or degenerative diseases like osteoarthritis are restrictive and painful...
Bone marrow-derived stromal cells (BMSCs) are good candidates for cell-based tissue regeneration. Fo...
Chondrogenesis of mesenchymal stem cells (MSCs) is typically induced when they are condensed into a ...
Cell therapy combined with biomaterial scaffolds is used to treat cartilage defects. We hypothesized...
Mesenchymal stem cells (MSCs) have been previously explored as a part of cell-based therapies for th...
Virtually all bone marrow-derived stromal cell (BMSC) chondrogenic induction cultures include greate...
Background Although mesenchymal stem/stromal cell (MSC) chondrogenic differentiation has been thoro...
Chondrocyte-based tissue engineering therapies require in vitro cell expansion, which is associated ...
Mesenchymal stem cells (MSCs) have been considered as a promising cell source for cartilage tissue r...